NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
ID: 356159Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the NCI Research Specialist (Clinician Scientist) Award (R50), a federal grant aimed at supporting clinician scientists involved in NCI-funded clinical trials. This funding opportunity is designed to enhance career stability for exceptional clinician scientists by providing salary support and sufficient autonomy, enabling them to lead national clinical trials and participate in trial networks without serving as principal investigators. The initiative reflects NIH's commitment to fostering leadership in cancer clinical research, ensuring qualified professionals contribute to the advancement of cancer treatment and care delivery. Applications will be accepted starting October 4, 2024, with a submission deadline of November 4, 2025, and interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Cancer Institute (NCI) is inviting applications for the Research Specialist Award (R50), aimed at supporting clinician scientists involved in NCI-funded clinical trials. This funding opportunity is designed to enhance career stability for exceptional clinician scientists by providing salary support and autonomy, allowing them to lead national clinical trials and participate in trial networks without serving as principal investigators. Applicants must have relevant clinical backgrounds, active licensure, and experience in NCI-related cancer clinical trials at their institutions. Key dates include an open application date on October 4, 2024, and all applications must be submitted before 5:00 PM local time of the applicant organization. Awards are contingent on NIH funding availability and are intended for a project period not exceeding five years. The application must comply with detailed submission instructions, including specific letters of support and comprehensive descriptions of the applicant’s role and contributions to clinical trials. This initiative reflects the NIH's dedication to fostering leadership in cancer clinical research, ensuring that qualified professionals contribute to the advancement of cancer treatment and care delivery.
    Similar Opportunities
    NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NCI Research Specialist (Core-based Scientist) Award (R50), a federal grant aimed at supporting laboratory-based scientists involved in cancer research. This funding opportunity is designed to provide salary support and promote stable career paths for exceptional researchers who contribute significantly to NCI-funded projects but do not serve as independent investigators. The initiative emphasizes the importance of collaborative scientific support in advancing cancer research and aims to foster a sustainable research workforce, particularly among institutions serving underrepresented groups. Applications are open from October 2, 2023, with awards expected as early as November 2023, and interested parties can find more information and submit inquiries via grantsinfo@nih.gov. The project duration can extend up to five years, with funding covering the Research Specialist's salary and limited travel costs.
    NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the Research Specialist Award (R50), aimed at supporting laboratory-based scientists engaged in cancer research. This grant is designed for exceptional individuals who wish to continue their research within existing NCI-funded programs without transitioning to independent investigator roles, emphasizing the importance of non-tenure track scientists in sustaining the biomedical research enterprise. Eligible applicants include various higher education institutions and organizations, with funding covering salary support and travel costs for a maximum project duration of five years. The application deadline is November 1, 2024, with an anticipated project start date in March 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI Research Specialist (Clinician Scientist) Award (R50), which will not allow clinical trials. This grant aims to support clinician scientists involved in NCI-funded clinical trials research by fostering stable research career opportunities and encouraging leadership in the development and implementation of clinical trials. The award is particularly significant as it seeks to enhance participation in NCI clinical trials networks, ensuring a diverse representation of institutions in the application process. The Notice of Funding Opportunity (NOFO) is expected to be published in late summer 2024, with a single application due date of November 5, 2024, and an estimated award date of May 30, 2025. Interested applicants should prepare their submissions accordingly, as applications are limited to four per institution.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)" aimed at supporting innovative preclinical and early-phase clinical research in cancer diagnosis, treatment, and prevention. This grant, with a funding ceiling of $275,000 over two years, encourages exploratory studies that may involve significant risk but have the potential to lead to breakthroughs in cancer research, particularly for underserved populations. Applications will be evaluated based on their significance, innovation, and rigor, with key deadlines for submission set for January 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at enhancing the number of independent physician-scientists in biomedical research. This program is specifically designed for outstanding postdoctoral researchers with clinical doctorate degrees who are transitioning from mentored positions to independent faculty roles, providing up to four years of funding divided into two phases: up to two years of mentored training followed by up to two years of independent research support. The initiative addresses the national shortage of physician-scientists and emphasizes the importance of a strong mentoring environment to facilitate successful transitions to research independence. Interested applicants must submit their proposals by January 7, 2026, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at supporting the transition of outstanding postdoctoral researchers with clinical doctorate degrees into independent research positions. This program seeks to address the national shortage of physician-scientists by providing a structured pathway that includes up to two years of mentored training followed by up to two years of independent research funding, contingent upon securing a tenure-track position. Eligible applicants include a diverse range of institutions such as higher education institutions, nonprofits, and certain health organizations, with applications evaluated based on the candidate's potential, career development plan, and the scientific merit of the proposed research. Interested parties should note that the application deadline is January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-071.html.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.